Law ❯ Litigation ❯ Class Action

Securities Class Action

Investor Rights Moderna, Inc. XPEL, Inc. Lululemon Athletica Inc. CVS Health Corporation Apple Inc. REGENXBIO, Inc. Dow Inc. Securities Unicycive Therapeutics Fortinet, Inc.

Ramaco Investors Face March 31 Deadline to Seek Lead Role in Securities Case

The early-stage lawsuit alleges the company misled the market about activity at its Brook Mine project.

Stories older than 24h

NuScale Investors Face April 20 Deadline in Securities Suit Over ENTRA1 Claims

BellRing Securities Lawsuit Spurs New Investor Alerts as Lead‑Plaintiff Deadline Approaches

Plug Power Investors Face April 3 Deadline to Seek Lead Role in Securities Class Action

Law Firms Urge Nektar Investors to Seek Lead Role in Securities Suit Over REZOLVE-AA Trial

Alight Investors Get May 15 Deadline To Seek Lead Plaintiff Role in Securities Class Action

Driven Brands Sued Over Accounting Restatement With Lead‑Plaintiff Deadline Set for May 8

Rosen and Schall Seek Lead Plaintiff in monday.com Securities Class Action

BellRing Securities Cases Push Toward March 23 Lead-Plaintiff Deadline

Picard Medical Investors Face April 13 Lead-Plaintiff Deadline in Securities Class Action

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in Securities Suit

NuScale Faces Securities Class Action Over ENTRA1 Disclosures After Cost Shock and Stock Slump

Investor Lawsuits Target Navan’s IPO Disclosures With Lead-Plaintiff Deadline on April 24

Investor Firms Vie to Lead Enphase Securities Class Actions Over Inventory, Tax-Credit Claims

CoreWeave Securities Lawsuit Enters Lead‑Plaintiff Phase Ahead of March 13 Deadline

Ardent Health Investors Get March 9 Deadline Reminder in Securities Class Action

Varonis Investors Urged to Act as March 9 Lead-Plaintiff Deadline Nears in Securities Class Action

Bath & Body Works Investors Face March 16 Deadline in Securities Class Action

Varonis Investors Urged to Seek Lead Role in SDNY Securities Suit as March 9 Deadline Nears

Blue Owl Securities Case Moves Toward Feb. 2 Lead‑Plaintiff Deadline Over Alleged BDC Redemption Strain